139 related articles for article (PubMed ID: 22407111)
1. Are adults just big children?
Emslie GJ
Am J Psychiatry; 2012 Mar; 169(3):248-50. PubMed ID: 22407111
[No Abstract] [Full Text] [Related]
2. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.
Hollander E; Soorya L; Chaplin W; Anagnostou E; Taylor BP; Ferretti CJ; Wasserman S; Swanson E; Settipani C
Am J Psychiatry; 2012 Mar; 169(3):292-9. PubMed ID: 22193531
[TBL] [Abstract][Full Text] [Related]
3. Pediatric clinical trial registration and trial results: an urgent need for improvement.
Denne SC
Pediatrics; 2012 May; 129(5):e1320-1. PubMed ID: 22529272
[No Abstract] [Full Text] [Related]
4. 'Use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'.
Bates G; Willson SW
Dev Med Child Neurol; 2003 May; 45(5):359; author reply 360. PubMed ID: 12729153
[No Abstract] [Full Text] [Related]
5. A child with severe head banging.
Granana N; Tuchman RF
Semin Pediatr Neurol; 1999 Sep; 6(3):221-4. PubMed ID: 10522343
[TBL] [Abstract][Full Text] [Related]
6. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
[TBL] [Abstract][Full Text] [Related]
7. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
[TBL] [Abstract][Full Text] [Related]
8. Citalopram for head-banging.
Vogel W; Stein DJ
J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):544-5. PubMed ID: 10802968
[No Abstract] [Full Text] [Related]
9. Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
Dinca O; Paul M; Spencer NJ
J Psychopharmacol; 2005 Sep; 19(5):521-32. PubMed ID: 16166190
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram treatment of stereotypic movement disorder in an adolescent with mitochondrial disorder and mental retardation.
Kalapatapu RK
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):313-6. PubMed ID: 19519269
[No Abstract] [Full Text] [Related]
12. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.
Carrasco M; Volkmar FR; Bloch MH
Pediatrics; 2012 May; 129(5):e1301-10. PubMed ID: 22529279
[TBL] [Abstract][Full Text] [Related]
13. The use of selective serotonin reuptake inhibitors in autism and related disorders.
Posey DJ; Erickson CA; Stigler KA; McDougle CJ
J Child Adolesc Psychopharmacol; 2006; 16(1-2):181-6. PubMed ID: 16553538
[TBL] [Abstract][Full Text] [Related]
14. Making a case to continue considering treatment with selective serotonin reuptake inhibitors for children with autism spectrum disorders.
Froehlich W
Curr Psychiatry Rep; 2011 Jun; 13(3):170-3. PubMed ID: 21404127
[No Abstract] [Full Text] [Related]
15. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
Soorya L; Kiarashi J; Hollander E
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368
[TBL] [Abstract][Full Text] [Related]
16. The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
Herscu P; Handen BL; Arnold LE; Snape MF; Bregman JD; Ginsberg L; Hendren R; Kolevzon A; Melmed R; Mintz M; Minshew N; Sikich L; Attalla A; King B; Owley T; Childress A; Chugani H; Frazier J; Cartwright C; Murphy T;
J Autism Dev Disord; 2020 Sep; 50(9):3233-3244. PubMed ID: 31267292
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of children and adolescents with pervasive developmental disorders.
Hanft A; Hendren RL
Essent Psychopharmacol; 2004; 6(1):12-24. PubMed ID: 15612651
[No Abstract] [Full Text] [Related]
18. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.
McDougle CJ; Kresch LE; Posey DJ
J Autism Dev Disord; 2000 Oct; 30(5):427-35. PubMed ID: 11098879
[TBL] [Abstract][Full Text] [Related]
19. Placebo response and the company it keeps.
Arnold LE
JAMA Pediatr; 2013 Nov; 167(11):1000-1. PubMed ID: 24061596
[No Abstract] [Full Text] [Related]
20. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
Okada T
Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
